Does targeting the lipophilic milieu provide advantages for an endothelin antagonist?

David M. Pollock, Erika I. Boesen, Stephen Matthew Black

Research output: Contribution to journalReview article

3 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)75-78
Number of pages4
JournalMolecular Interventions
Volume9
Issue number2
DOIs
StatePublished - Apr 1 2009

Fingerprint

Endothelin Receptors
Endothelin-1
Drug Discovery
Drug Delivery Systems
Protein Binding
Endothelin Receptor Antagonists

ASJC Scopus subject areas

  • Molecular Medicine

Cite this

Does targeting the lipophilic milieu provide advantages for an endothelin antagonist? / Pollock, David M.; Boesen, Erika I.; Black, Stephen Matthew.

In: Molecular Interventions, Vol. 9, No. 2, 01.04.2009, p. 75-78.

Research output: Contribution to journalReview article

Pollock, David M. ; Boesen, Erika I. ; Black, Stephen Matthew. / Does targeting the lipophilic milieu provide advantages for an endothelin antagonist?. In: Molecular Interventions. 2009 ; Vol. 9, No. 2. pp. 75-78.
@article{eefd4aa3e6e0412a85d2af9993aa39e7,
title = "Does targeting the lipophilic milieu provide advantages for an endothelin antagonist?",
author = "Pollock, {David M.} and Boesen, {Erika I.} and Black, {Stephen Matthew}",
year = "2009",
month = "4",
day = "1",
doi = "10.1124/mi.9.2.6",
language = "English (US)",
volume = "9",
pages = "75--78",
journal = "Molecular Interventions",
issn = "1534-0384",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "2",

}

TY - JOUR

T1 - Does targeting the lipophilic milieu provide advantages for an endothelin antagonist?

AU - Pollock, David M.

AU - Boesen, Erika I.

AU - Black, Stephen Matthew

PY - 2009/4/1

Y1 - 2009/4/1

UR - http://www.scopus.com/inward/record.url?scp=65949120920&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=65949120920&partnerID=8YFLogxK

U2 - 10.1124/mi.9.2.6

DO - 10.1124/mi.9.2.6

M3 - Review article

C2 - 19401539

AN - SCOPUS:65949120920

VL - 9

SP - 75

EP - 78

JO - Molecular Interventions

JF - Molecular Interventions

SN - 1534-0384

IS - 2

ER -